151 related articles for article (PubMed ID: 27387133)
1. Cathepsin S attenuates endosomal EGFR signalling: A mechanical rationale for the combination of cathepsin S and EGFR tyrosine kinase inhibitors.
Huang CC; Lee CC; Lin HH; Chang JY
Sci Rep; 2016 Jul; 6():29256. PubMed ID: 27387133
[TBL] [Abstract][Full Text] [Related]
2. EGF‑stimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinib‑resistant human lung cancer cell line.
Nishimura Y; Takiguchi S; Ito S; Itoh K
Int J Oncol; 2015 Apr; 46(4):1721-9. PubMed ID: 25653196
[TBL] [Abstract][Full Text] [Related]
3. Targeting cathepsin S induces tumor cell autophagy via the EGFR-ERK signaling pathway.
Chen KL; Chang WS; Cheung CH; Lin CC; Huang CC; Yang YN; Kuo CP; Kuo CC; Chang YH; Liu KJ; Wu CM; Chang JY
Cancer Lett; 2012 Apr; 317(1):89-98. PubMed ID: 22101325
[TBL] [Abstract][Full Text] [Related]
4. [The association of a protein regulator of intracellular Rab7 membrane transport with endosomes containing an epidermal growth factor receptor with activated and inactivated tyrosine kinase].
Blagoveshchenskaia AD; Vinogradova NA; Nikol'skiĭ NN; Kornilova ES
Tsitologiia; 1996; 38(8):854-62. PubMed ID: 9027015
[TBL] [Abstract][Full Text] [Related]
5. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.
Huang S; Armstrong EA; Benavente S; Chinnaiyan P; Harari PM
Cancer Res; 2004 Aug; 64(15):5355-62. PubMed ID: 15289342
[TBL] [Abstract][Full Text] [Related]
6. Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by Gefitinib and Cetuximab triggered antibody-dependent cellular cytotoxicity.
Amaro A; Mirisola V; Angelini G; Musso A; Tosetti F; Esposito AI; Perri P; Lanza F; Nasciuti F; Mosci C; Puzone R; Salvi S; Truini M; Poggi A; Pfeffer U
Eur J Cancer; 2013 Oct; 49(15):3353-65. PubMed ID: 23849826
[TBL] [Abstract][Full Text] [Related]
7. Melatonin attenuates epidermal growth factor-induced cathepsin S expression in ARPE-19 cells: Implications for proliferative vitreoretinopathy.
Yang SF; Chen YS; Chien HW; Wang K; Lin CL; Chiou HL; Lee CY; Chen PN; Hsieh YH
J Pineal Res; 2020 Jan; 68(1):e12615. PubMed ID: 31605630
[TBL] [Abstract][Full Text] [Related]
8. Autophagy-Regulated ROS from Xanthine Oxidase Acts as an Early Effector for Triggering Late Mitochondria-Dependent Apoptosis in Cathepsin S-Targeted Tumor Cells.
Huang CC; Lee CC; Lin HH; Chen MC; Lin CC; Chang JY
PLoS One; 2015; 10(6):e0128045. PubMed ID: 26029922
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
Lee LT; Huang YT; Hwang JJ; Lee PP; Ke FC; Nair MP; Kanadaswam C; Lee MT
Anticancer Res; 2002; 22(3):1615-27. PubMed ID: 12168845
[TBL] [Abstract][Full Text] [Related]
10. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
Li B; Chang CM; Yuan M; McKenna WG; Shu HK
Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
[TBL] [Abstract][Full Text] [Related]
11. Re-localization of activated EGF receptor and its signal transducers to multivesicular compartments downstream of early endosomes in response to EGF.
Oksvold MP; Skarpen E; Wierød L; Paulsen RE; Huitfeldt HS
Eur J Cell Biol; 2001 Apr; 80(4):285-94. PubMed ID: 11370743
[TBL] [Abstract][Full Text] [Related]
12. Dynamin II function is required for EGF-mediated Stat3 activation but not Erk1/2 phosphorylation.
Luwor RB; Chin X; McGeachie AB; Robinson PJ; Zhu HJ
Growth Factors; 2012 Aug; 30(4):220-9. PubMed ID: 22574813
[TBL] [Abstract][Full Text] [Related]
13. Acute ligand-independent Src activation mimics low EGF-induced EGFR surface signalling and redistribution into recycling endosomes.
Medts T; de Diesbach P; Cominelli A; N'Kuli F; Tyteca D; Courtoy PJ
Exp Cell Res; 2010 Nov; 316(19):3239-53. PubMed ID: 20832399
[TBL] [Abstract][Full Text] [Related]
14. Combining RNA interference and kinase inhibitors against cell signalling components involved in cancer.
O'Grady M; Raha D; Hanson BJ; Bunting M; Hanson GT
BMC Cancer; 2005 Oct; 5():125. PubMed ID: 16202132
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of cathepsin S expression by HSP90 and 5-HT
Gautam J; Bae YK; Kim JA
Breast Cancer Res Treat; 2017 Jan; 161(1):29-40. PubMed ID: 27796714
[TBL] [Abstract][Full Text] [Related]
16. Concomitant inactivation of the epidermal growth factor receptor, phosphatidylinositol 3-kinase/Akt and Janus tyrosine kinase 2/signal transducer and activator of transcription 3 signalling pathways in cardiotoxin III-treated A549 cells.
Su JC; Lin KL; Chien CM; Chuang PW; Chang LS; Lin SR
Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):833-40. PubMed ID: 20456425
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cathepsin S induces autophagy and apoptosis in human glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K and JNK signaling pathways.
Zhang L; Wang H; Xu J; Zhu J; Ding K
Toxicol Lett; 2014 Aug; 228(3):248-59. PubMed ID: 24875536
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin Inhibition Prevents Autophagic Protein Turnover and Downregulates Insulin Growth Factor-1 Receptor-Mediated Signaling in Neuroblastoma.
Soori M; Lu G; Mason RW
J Pharmacol Exp Ther; 2016 Feb; 356(2):375-86. PubMed ID: 26660229
[TBL] [Abstract][Full Text] [Related]
19. Non-Ligand-Induced Dimerization is Sufficient to Initiate the Signalling and Endocytosis of EGF Receptor.
Kourouniotis G; Wang Y; Pennock S; Chen X; Wang Z
Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27463710
[TBL] [Abstract][Full Text] [Related]
20. Targeting of EGFR tyrosine kinase by ZD1839 ("Iressa") in androgen-responsive prostate cancer in vitro.
Bellezza I; Bracarda S; Caserta C; Minelli A
Mol Genet Metab; 2006 Jun; 88(2):114-22. PubMed ID: 16487738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
